BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18375411)

  • 1. Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes.
    Gouni-Berthold I; Berthold HK; Mantzoros CS; Böhm M; Krone W
    Diabetes Care; 2008 Jul; 31(7):1389-91. PubMed ID: 18375411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: Translating Research Into Action for Diabetes (TRIAD) Study.
    Ferrara A; Mangione CM; Kim C; Marrero DG; Curb D; Stevens M; Selby JV;
    Diabetes Care; 2008 Jan; 31(1):69-74. PubMed ID: 17934157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in composite control of cardiovascular risk factors among patients with type 2 diabetes.
    Strom Williams JL; Lynch CP; Winchester R; Thomas L; Keith B; Egede LE
    Diabetes Technol Ther; 2014 Jul; 16(7):421-7. PubMed ID: 24735058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent contribution of A1C, systolic blood pressure, and LDL cholesterol control to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study.
    Nichols GA; Joshua-Gotlib S; Parasuraman S
    J Gen Intern Med; 2013 May; 28(5):691-7. PubMed ID: 23345072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherosclerotic disease location and disparities in the control and treatment of cardiovascular risk factors in patients with Type 2 diabetes.
    Berthold HK; Bestehorn KP; Krone W; Gouni-Berthold I
    Diabet Med; 2010 Mar; 27(3):303-8. PubMed ID: 20536493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register.
    Karlsson SA; Franzén S; Svensson AM; Miftaraj M; Eliasson B; Andersson Sundell K
    BMC Health Serv Res; 2018 Nov; 18(1):900. PubMed ID: 30486824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes.
    Wexler DJ; Grant RW; Meigs JB; Nathan DM; Cagliero E
    Diabetes Care; 2005 Mar; 28(3):514-20. PubMed ID: 15735180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in cardiovascular risk factors in incident diabetes.
    Schroeder EB; Bayliss EA; Daugherty SL; Steiner JF
    Womens Health Issues; 2014; 24(1):e61-8. PubMed ID: 24439948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey.
    Charpentier G; Genès N; Vaur L; Amar J; Clerson P; Cambou JP; Guéret P;
    Diabetes Metab; 2003 Apr; 29(2 Pt 1):152-8. PubMed ID: 12746636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentially modifiable metabolic factors and the risk of cardiovascular disease hospitalizations in urban African Americans with diabetes.
    Cook CB; Hentz JG; Tsui C; Ziemer DC; Naylor DB; Miller WJ
    Ethn Dis; 2006; 16(4):852-8. PubMed ID: 17061737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes: findings from the Dutch Diabetes Pearl cohort.
    de Jong M; Oskam MJ; Sep SJS; Ozcan B; Rutters F; Sijbrands EJG; Elders PJM; Siegelaar SE; DeVries JH; Tack CJ; Schroijen M; de Valk HW; Abbink EJ; Stehouwer CDA; Jazet I; Wolffenbuttel BHR; Peters SAE; Schram MT;
    BMJ Open Diabetes Res Care; 2020 Oct; 8(1):. PubMed ID: 33023896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-specific differences in glycemic control and cardiovascular risk factors in older patients with insulin-treated type 2 diabetes mellitus.
    Göbl CS; Brannath W; Bozkurt L; Handisurya A; Anderwald C; Luger A; Krebs M; Kautzky-Willer A; Bischof MG
    Gend Med; 2010 Dec; 7(6):593-9. PubMed ID: 21195359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk factors among youth with and without type 2 diabetes: differences and possible mechanisms.
    West NA; Hamman RF; Mayer-Davis EJ; D'Agostino RB; Marcovina SM; Liese AD; Zeitler PS; Daniels SR; Dabelea D
    Diabetes Care; 2009 Jan; 32(1):175-80. PubMed ID: 18945923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in the effect of HbA1c-defined diabetes on a wide range of cardiovascular disease risk factors.
    Du T; Yuan G; Zhou X; Sun X
    Ann Med; 2016; 48(1-2):34-41. PubMed ID: 26758477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening for hyperlipidemia in cardiovascular high-risk patients in austrian diabetes ambulances].
    Brath H; Wascher TC; Kästenbauer T; Toplak H
    MMW Fortschr Med; 2012 Jun; 154 Suppl 2():41-7. PubMed ID: 23424754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive glycaemic control in type 2 diabetes mellitus: does it improve cardiovascular outcomes?
    Reddy SV; Bhatia E
    Natl Med J India; 2011; 24(1):21-7. PubMed ID: 21608354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressive symptoms, serious psychological distress, diabetes distress and cardiovascular risk factor control in patients with type 2 diabetes.
    Winchester RJ; Williams JS; Wolfman TE; Egede LE
    J Diabetes Complications; 2016 Mar; 30(2):312-7. PubMed ID: 26657725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender-Related Differences in the Control of Cardiovascular Risk Factors in Primary Care for Elderly Patients With Type 2 Diabetes: A Cohort Study.
    Al-Salameh A; Bucher S; Bauduceau B; Benattar-Zibi L; Berrut G; Bertin P; Corruble E; Danchin N; Derumeaux G; Doucet J; Falissard B; Forette F; Hanon O; Ourabah R; Pasquier F; Pinget M; Ringa V; Becquemont L
    Can J Diabetes; 2018 Aug; 42(4):365-371.e2. PubMed ID: 29037572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel determinants preventing achievement of major cardiovascular targets in type 2 diabetes.
    Camara S; Bouenizabila E; Hermans MP; Ahn SA; Rousseau MF
    Diabetes Metab Syndr; 2014; 8(3):145-51. PubMed ID: 25220917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological primary and secondary cardiovascular prevention among diabetic patients in a multiethnic general practice population: still room for improvements.
    Tran AT; Straand J; Dalen I; Birkeland KI; Claudi T; Cooper JG; Meyer HE; Jenum AK
    BMC Health Serv Res; 2013 May; 13():182. PubMed ID: 23688317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.